A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer
about
Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancerCyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4Cyclin D1 and Rb protein expression and their correlation with prognosis in patients with colon cancer.Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients.Cyclin D1 in breast cancerInhibition of human breast cancer cell growth by blockade of the mevalonate-protein prenylation pathway is not prevented by overexpression of cyclin D1.Cyclins and breast cancer.The relationship between prognostic and predictive factors in the management of breast cancer.Cell cycle regulators and their abnormalities in breast cancer.Expression of cell cycle proteins in male breast carcinoma.Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer.High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers.Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.Expression of the cell cycle regulatory proteins p34cdc2, p21waf1, and p53 in node negative invasive ductal breast carcinoma.Regulation of the functional interaction between cyclin D1 and the estrogen receptor.Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 functionDifferential expression of breast cancer-associated genes between stage- and age-matched tumor specimens from African- and Caucasian-American Women diagnosed with breast cancer.An overview of the role and inter-relationship of epidermal growth factor receptor, cyclin D and retinoblastoma protein on the carcinogenesis of squamous cell carcinoma of the larynx.Cooperative interactions of HER-2 and HPV-16 oncoproteins in the malignant transformation of human mammary epithelial cells.Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer.Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value.Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC studyFrequent alterations of cell cycle regulators in early-stage breast lesions as detected by immunohistochemistryPI-3K/Akt pathway-dependent cyclin D1 expression is responsible for arsenite-induced human keratinocyte transformation.Correlation between cyclin D1 expression and standard clinicopathological variables in invasive breast cancer in Eastern IndiaCyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment.Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence.Correlation of cyclin D1 and Rb gene expression with apoptosis in invasive breast cancer.Concerted overexpression of the genes encoding p21 and cyclin D1 is associated with growth inhibition and differentiation in various carcinomas.Longer survival in patients with breast cancer with cyclin d1 over-expression after tumor recurrence: longer, but occupied with diseaseResistance to antiestrogen arzoxifene is mediated by overexpression of cyclin D1.The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node.Cyclin D1 and human neoplasiaCyclin D1 expression in human prostate carcinoma cell lines and primary tumors.Cyclin D1 in mammary carcinoma.Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers.PI3K/Akt/JNK/c-Jun signaling pathway is a mediator for arsenite-induced cyclin D1 expression and cell growth in human bronchial epithelial cells.Immunohistochemical Expression of p53 in Pleomorphic Adenoma and Carcinoma Ex Pleomorphic Adenoma.CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome.
P2860
Q24633201-7135030F-E72D-4C6B-95D2-C00B50F37621Q24644847-BBDBDECA-3F3A-4729-8128-F12715B6DD1DQ25257909-99A8E720-1045-44FC-86D3-862E88D6A89AQ27824813-3FE30264-6838-4BC7-AFCA-E25CC2828E06Q28138175-CB3C3064-BAF8-4C6E-81F5-3DA818000477Q31957656-508E4C69-76F4-41EF-9CE3-4698565D27A6Q33538420-B96E9F8B-9451-44A2-AB8D-1920B5C9F0ADQ33538455-498BB383-AF79-45DC-B777-7F15D3BFEFCCQ33588357-A8ACE3DF-15AD-4B8C-8022-427499C68FBEQ33692284-E078E349-5490-4337-AC3E-5356E301246BQ33822845-DEBA143C-2F78-48A6-B22E-C136FAB0989AQ33867326-AFB72151-F503-4C08-AECA-613E0634C7F1Q33903965-F8A50D6F-D78A-47E0-B1DD-07F0EBA1FA22Q33919277-FA14E4C7-E294-49D1-B45E-CFDE98E18710Q33966444-0ABBB5C5-F9AC-478F-A488-7552977A88D7Q33967106-9609E8B3-58B8-4821-B637-D5118B301964Q34278253-3E8733F0-2661-4767-9635-5F7595573B2DQ34370811-A03C222A-7229-4749-B541-BEFD87D46D1FQ34769657-A845AF6A-9C2B-4169-9E4A-C33F4F10BB87Q35538100-5BDC72AF-8D15-4AA1-87A5-D6D6C6EAE6D1Q35764646-FF0197D9-416B-46CF-8BF4-10A65C302A60Q36175746-C0AEBFF9-ADBD-4397-AA9C-D5BA449C3A66Q36245589-258C68D4-8DA4-46AE-B608-34EB8F25EFB9Q36292511-AB29F297-674E-429A-BBE7-5E20A5A75C61Q36381304-ED18ACA2-8463-40BA-A237-3AB3FB0B56EAQ36634397-8399B5BE-81E0-49A3-B6C3-88BCA647968DQ36643848-61A3D369-5DFF-4EBF-A1D7-E59A1F002BCFQ36671557-A876F4C1-B662-4C75-985F-CCAE9A516F6FQ37640655-A12603C5-FBDA-4E4A-961B-0577BE8E9727Q37641907-30E943CB-9447-4F9B-A64A-583CA99A30A0Q37705398-CC7CF2E0-042D-4D85-8D4B-FFF184F97AD6Q39845800-FC04F521-2259-4A12-BF85-2C3F0111D28CQ40720961-7041E555-9BE8-412F-BA58-215C41A0858BQ40794379-AAA56691-35D4-4043-9B6C-BB37F91E6088Q41046879-2DF31FA5-C142-441A-BE99-1FE681336EBBQ41474265-C628CFDB-2AC7-423A-99BF-3424FE774ED2Q41855173-07756051-A420-41C2-9719-F6FA70668BC0Q41881135-F6C0CC6F-E956-471D-BF76-2D01D8DB8F75Q42035172-76C21F8D-BCB4-42AF-9411-2CCF827941FBQ42516415-0EE464A4-CFB9-42DC-AC37-96EC3DC1818F
P2860
A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
A clinicopathological study on ...... ts with operable breast cancer
@ast
A clinicopathological study on ...... ts with operable breast cancer
@en
type
label
A clinicopathological study on ...... ts with operable breast cancer
@ast
A clinicopathological study on ...... ts with operable breast cancer
@en
prefLabel
A clinicopathological study on ...... ts with operable breast cancer
@ast
A clinicopathological study on ...... ts with operable breast cancer
@en
P2093
P2860
P356
P1476
A clinicopathological study on ...... ts with operable breast cancer
@en
P2093
Klompmaker R
Michalides R
Wientjens E
van Tinteren H
P2860
P2888
P304
P356
10.1038/BJC.1996.128
P407
P577
1996-03-01T00:00:00Z
P5875
P6179
1023355093